GENEVA, Oct. 13 -- KINIKSA PHARMACEUTICALS, GMBH (Grafenaustrasse 56302 Zug) filed a patent application (PCT/IB2025/053431) for "HUMANIZED ANTI-CD40 ANTIBODIES FOR TREATING SJOGREN'S DISEASE" on Apr 01, 2025. With publication no. WO/2025/210517, the details related to the patent application was published on Oct 09, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): PAOLINI, John F. (100 Hayden AvenueLexington, Massachusetts 02421), TESSARI, Eben (100 Hayden AvenueLexington, Massachusetts 02421)
Abstract: The present disclosure relates to dosing regimens of pharmaceutical compositions of anti- ...